349
Views
2
CrossRef citations to date
0
Altmetric
Review Article

Cannabinoids: Recent Updates on Public Perception, Adverse Reactions, Pharmacokinetics, Pretreatment Methods and Their Analysis Methods

, ORCID Icon, &
Pages 1197-1222 | Published online: 09 Feb 2021

Reference

  • Watanabe, K. Cannabinoids and Their Metabolites. 2005.
  • ElSohly, M. A.; Slade, D. Chemical Constituents of Marijuana: The Complex Mixture of Natural Cannabinoids. Life Sci. 2005, 78, 539–548. DOI: 10.1016/j.lfs.2005.09.011.
  • Hermanns-Clausen, M.; Kneisel, S.; Szabo, B.; Auwärter, V. Acute Toxicity Due to the Confirmed Consumption of Synthetic Cannabinoids: Clinical and Laboratory Findings. Addiction 2013, 108, 534–544. DOI: 10.1111/j.1360-0443.2012.04078.x.
  • Vardakou, I.; Pistos, C.; Spiliopoulou, C. Spice Drugs as a New Trend: Mode of Action, Identification and Legislation. Toxicol. Lett. 2010, 197, 157–162. DOI: 10.1016/j.toxlet.2010.06.002.
  • Jain, R.; Singh, R. Microextraction Techniques for Analysis of Cannabinoids. Trends Anal. Chem. 2016, 80, 156–166. DOI: 10.1016/j.trac.2016.03.012.
  • Presley, B. C.; Jansen-Varnum, S. A.; Logan, B. K. Analysis of Synthetic Cannabinoids in Botanical Material: A Review of Analytical Methods and Findings. Forensic. Sci. Rev. 2013, 25, 27–46.
  • Leghissa, A.; Hildenbrand, Z. L.; Schug, K. A. A Review of Methods for the Chemical Characterization of Cannabis Natural Products. J. Sep. Sci. 2018, 41, 398–415. DOI: 10.1002/jssc.201701003.
  • Rosado, T.; Goncalves, J.; Luis, Â.; Malaca, S.; Soares, S.; Vieira, D. N.; Barroso, M.; Gallardo, E. Synthetic Cannabinoids in Biological Specimens: A Review of Current Analytical Methods and Sample Preparation Techniques. Bioanalysis 2018, 10, 1609–1623. DOI: 10.4155/bio-2018-0150.
  • Joanna, Z.; Pavlína, G.; Jan, P.; Peter, O.; Ivo, V.; Juraj, Š.; Jan, C.; Vítězslav, M. Determination and Identification of Synthetic Cannabinoids and Their Metabolites in Different Matrices by Modern Analytical Techniques - a Review. Anal. Chim. Acta 2015, 874, 11.
  • Citti, C.; Braghiroli, D.; Vandelli, M. A.; Cannazza, G. Pharmaceutical and Biomedical Analysis of Cannabinoids: A Critical Review. J. Pharm. Biomed. Anal. 2018, 147, 565–579. DOI: 10.1016/j.jpba.2017.06.003.
  • Musto, D. F. Opium, Cocaine and Marijuana in American History. Sci. Am. 1991, 265, 40–47. DOI: 10.1038/scientificamerican0791-40.
  • Compton, W. M.; Han, B.; Jones, C. M.; Blanco, C.; Hughes, A. Marijuana Use and Use Disorders in Adults in the USA, 2002–14: Analysis of Annual Cross-Sectional Surveys. Lancet Psychiatr. 2016, 3, 954–964. DOI: 10.1016/S2215-0366(16)30208-5.
  • Azofeifa, A.; Mattson, M. E.; Schauer, G.; McAfee, T.; Grant, A.; Lyerla, R. National Estimates of Marijuana Use and Related Indicators - National Survey on Drug Use and Health, United States, 2002-2014. MMWR Surveill. Summ. 2016, 65, 1–28. DOI: 10.15585/mmwr.ss6511a1.
  • Castaneto, M. S.; Gorelick, D. A.; Desrosiers, N. A.; Hartman, R. L.; Pirard, S.; Huestis, M. A. Synthetic Cannabinoids: Epidemiology, Pharmacodynamics, and Clinical Implications. Drug Alcohol Depend. 2014, 144, 12–41. DOI: 10.1016/j.drugalcdep.2014.08.005.
  • Wiley, J. L.; Marusich, J. A.; Huffman, J. W. Moving around the Molecule: Relationship between Chemical Structure and in Vivo Activity of Synthetic Cannabinoids. Life Sci. 2014, 97, 55–63. DOI: 10.1016/j.lfs.2013.09.011.
  • Cottone, E.; Pomatto, V.; Cerri, F.; Campantico, E.; Mackie, K.; Delpero, M.; Guastalla, A.; Dati, C.; Bovolin, P.; Franzoni, M. F. Cannabinoid Receptors Are Widely Expressed in Goldfish: Molecular Cloning of a CB2-like Receptor and Evaluation of CB1 and CB2 mRNA Expression Profiles in Different Organs. Fish Physiol. Biochem. 2013, 39, 1287–1296. DOI: 10.1007/s10695-013-9783-9.
  • Howlett, A. C.; Barth, F.; Bonner, T. I.; Cabral, G.; Casellas, P.; Devane, W. A.; Felder, C. C.; Herkenham, M.; Mackie, K.; Martin, B. R.; et al. International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors. Pharmacol. Rev. 2002, 54, 161–202., DOI: 10.1124/pr.54.2.161.
  • Ashton, J. C.; Friberg, D.; Darlington, C. L.; Smith, P. F. Expression of the Cannabinoid CB2 Receptor in the Rat Cerebellum: An Immunohistochemical Study. Neurosci. Lett. 2006, 396, 113–116. DOI: 10.1016/j.neulet.2005.11.038.
  • Chou, R.; Deyo, R.; Devine, B.; Hansen, R.; Sullivan, S.; Jarvik, J. G.; Blazina, I.; Dana, T.; Bougatsos, C.; Turner, J. The Effectiveness and Risks of Long-Term Opioid Treatment of Chronic Pain. Evid. Rep. Technol. Assess. (Full Rep.) 2014, 1–219.
  • Volkow, N. D.; Mclellan, A. T. Opioid Abuse in Chronic Pain-Misconceptions and Mitigation Strategies. N. Engl. J. Med. 2016, 374, 1253–1263. DOI: 10.1056/NEJMra1507771.
  • Choo, E. K.; Ewing, S. W. F.; Lovejoy, T. I. Opioids out, Cannabis in: Negotiating the Unknowns in Patient Care for Chronic Pain. JAMA 2016, 316, 1763–1764. DOI: 10.1001/jama.2016.13677.
  • Saxon, A. J.; Browne, K. W. Marijuana Not Ready for Prime Time as an Analgesic. Gen. Hosp. Psychiatry. 2014, 36, 4–6. DOI: 10.1016/j.genhosppsych.2013.08.005.
  • Walsh, Z.; Gonzalez, R.; Crosby, K.; S Thiessen, M.; Carroll, C.; Bonn-Miller, M. O. Medical Cannabis and Mental Health: A Guided Systematic Review. Clin. Psychol. Rev. 2017, 51, 15–29. DOI: 10.1016/j.cpr.2016.10.002.
  • Bonnmiller, M. O.; Boden, M. T.; Bucossi, M. M.; Babson, K. A. Self-Reported Cannabis Use Characteristics, Patterns and Helpfulness among Medical Cannabis Users. Am. J. Drug Alcohol Abuse 2014, 40, 23.
  • Piper, B. J.; Dekeuster, R. M.; Beals, M. L.; Cobb, C. M.; Burchman, C. A.; Perkinson, L.; Lynn, S. T.; Nichols, S. D.; Abess, A. T. Substitution of Medical Cannabis for Pharmaceutical Agents for Pain, Anxiety, and Sleep. J. Psychopharmacol. 2017, 31, 569–575. DOI: 10.1177/0269881117699616.
  • Bahorik, A. L.; Leibowitz, A.; Sterling, S. A.; Travis, A.; Weisner, C.; Satre, D. D. Patterns of Marijuana Use among Psychiatry Patients with Depression and Its Impact on Recovery. J. Affect. Disord. 2017, 213, 168–171. DOI: 10.1016/j.jad.2017.02.016.
  • Mir, A.; Obafemi, A. I.; Young, A.; Kane, C. E. Myocardial Infarction Associated with Use of the Synthetic Cannabinoid K2. Pediatrics 2011, 128, e1622–e1627. DOI: 10.1542/peds.2010-3823.
  • Vandrey, R. G.; Dunn, K. E.; Fry, J. A.; Girling, E. R. A Survey Study to Characterize Use of Spice Products (Synthetic Cannabinoids). Drug Alcohol Depend. 2012, 120, 238–241. DOI: 10.1016/j.drugalcdep.2011.07.011.
  • Drenzek, C.; Geller, R. J.; Steck, A.; Arnold, J.; Lopez, G.; Gerona, R.; Edison, L. Severe Illness Associated with Synthetic Cannabinoid Use — Brunswick, Georgia. MMWR Morb. Mortal. Wkly. Rep. 2013, 62, 939.
  • Buser, G. L.; Gerona, R.; Horowitz, B.; Vian, K. P.; Troxell, M. L.; Hendrickson, R. G.; Houghton, D. C.; Rozansky, D.; Su, S. W.; Leman, R. Acute Kidney Injury Associated with Smoking Synthetic Cannabinoid. Clin. Toxicol. (Phila.) 2014, 52, 664–673. DOI: 10.3109/15563650.2014.932365.
  • Hall, W. The Adverse Health Effects of Cannabis Use: What Are They, and What Are Their Implications for Policy? Int. J. Drug Policy 2009, 20, 458–466. DOI: 10.1016/j.drugpo.2009.02.013.
  • Volkow, N. D.; Baler, R. D.; Compton, W. M.; Weiss, S. R. B. Adverse Health Effects of Marijuana Use. N. Engl. J. Med. 2014, 370, 2219–2227. DOI: 10.1056/NEJMra1402309.
  • Kahan, M.; Srivastava, A.; Spithoff, S.; Bromley, L. Prescribing Smoked Cannabis for Chronic Noncancer Pain: Preliminary Recommendations. Can. Fam. Physician 2014, 60, 1083–1090.
  • Thomas, G.; Kloner, R. A.; Rezkalla, S. H. Adverse Cardiovascular, Cerebrovascular, and Peripheral Vascular Effects of Marijuana Inhalation: What Cardiologists Need to Know. Am. J. Cardiol. 2014, 113, 187–190. DOI: 10.1016/j.amjcard.2013.09.042.
  • James, A. A.; James, C.; Thwaites, T. The Brain Effects of Cannabis in Healthy Adolescents and in Adolescents with Schizophrenia: A Systematic Review. Psychiatry Res. 2013, 214, 181–189. DOI: 10.1016/j.pscychresns.2013.07.012.
  • Lisdahl, K. M.; Wright, N. E.; Kirchner-Medina, C.; Maple, K. E.; Shollenbarger, S. Considering Cannabis: The Effects of Regular Cannabis Use on Neurocognition in Adolescents and Young Adults. Curr. Addict. Rep. 2014, 1, 144–156. DOI: 10.1007/s40429-014-0019-6.
  • Meier, M. H.; Caspi, A.; Ambler, A.; Harrington, H.; Houts, R.; Keefe, R. S. E.; Mcdonald, K.; Ward, A. L.; Poulton, R.; Moffitt, T. E. Persistent Cannabis Users Show Neuropsychological Decline from Childhood to Midlife. Proc. Natl. Acad. Sci. U. S. A. 2012, 109, E2657–E2664. DOI: 10.1073/pnas.1206820109.
  • Yucel, M.; Solowij, N.; Respondek, C.; Whittle, S.; Fornito, A.; Pantelis, C.; Lubman, D. I. Regional Brain Abnormalities Associated with Long-Term Heavy Cannabis Use. Arch. Gen. Psychiatry 2008, 65, 694. DOI: 10.1001/archpsyc.65.6.694.
  • Milin, R.; Manion, I.; Dare, G. J.; Walker, S. Prospective Assessment of Cannabis Withdrawal in Adolescents with Cannabis Dependence: A Pilot Study. J. Am. Acad. Child Adolesc. Psychiatry 2008, 47, 174–179. DOI: 10.1097/chi.0b013e31815cdd73.
  • Lin, C. Y.; Wheelock, A. M.; Morin, D.; Baldwin, R. M.; Lee, M. G.; Taff, A.; Plopper, C.; Buckpitt, A.; Rohde, A. Toxicity and Metabolism of Methylnaphthalenes: Comparison with Naphthalene and 1-Nitronaphthalene. Toxicology 2009, 260, 16–27. DOI: 10.1016/j.tox.2009.03.002.
  • Brents, L. K.; Gallus-Zawada, A.; Radominska-Pandya, A.; Vasiljevik, T.; Prisinzano, T. E.; Fantegrossi, W. E.; Moran, J. H.; Prather, P. L. Monohydroxylated Metabolites of the K2 Synthetic Cannabinoid JWH-073 Retain Intermediate to High Cannabinoid 1 Receptor (CB1R) Affinity and Exhibit Neutral Antagonist to Partial Agonist Activity. Biochem. Pharmacol. 2012, 83, 952–961. DOI: 10.1016/j.bcp.2012.01.004.
  • Cannaert, A.; Storme, J.; Franz, F.; Auwärter, V.; Stove, C. P. Detection and Activity Profiling of Synthetic Cannabinoids and Their Metabolites with a Newly Developed Bioassay. Anal. Chem. 2016, 88, 11476–11485. DOI: 10.1021/acs.analchem.6b02600.
  • Escrivá, Ú.; Andrés-Costa, M. J.; Andreu, V.; Picó, Y. Analysis of Cannabinoids by Liquid chromatography-Mass Spectrometry in Milk, Liver and Hemp Seed to Ensure Food Safety. Food Chem. 2017, 228, 177–185. DOI: 10.1016/j.foodchem.2017.01.128.
  • Brents, L. K.; Reichard, E. E.; Zimmerman, S. M.; Moran, J. H.; Fantegrossi, W. E.; Prather, P. L. Phase I Hydroxylated Metabolites of the K2 Synthetic Cannabinoid JWH-018 Retain In Vitro and In Vivo Cannabinoid 1 Receptor Affinity and Activity. PLoS One 2011, 6, e21917. DOI: 10.1371/journal.pone.0021917.
  • Moore, K. N.; Garvin, D.; Thomas, B. F.; Grabenauer, M. Identification of Eight Synthetic Cannabinoids, Including 5F-AKB48 in Seized Herbal Products Using DART-TOF-MS and LC-QTOF-MS as Nontargeted Screening Methods. J. Forensic Sci. 2017, 62, 1151–1158. DOI: 10.1111/1556-4029.13367.
  • Musah, R. A.; Domin, M. A.; Cody, R. B.; Lesiak, A. D.; Dane, A. J.; Shepard, J. R. E. Direct Analysis in Real Time Mass Spectrometry with Collision-Induced Dissociation for Structural Analysis of Synthetic Cannabinoids. Rapid Commun. Mass. Spectrom. 2012, 26, 2335–2342. DOI: 10.1002/rcm.6354.
  • Cody, R. B.; Laramee, J. A.; Durst, H. D. Versatile New Ion Source for the Analysis of Materials in Open Air under Ambient Conditions. Anal. Chem. 2005, 77, 2297–2302. DOI: 10.1021/ac050162j.
  • Wohlfarth, A.; Scheidweiler, K. B.; Chen, X.; Liu, H.; Huestis, M. A. Qualitative Confirmation of 9 Synthetic Cannabinoids and 20 Metabolites in Human Urine Using LC-MS/MS and Library Search. Anal. Chem. 2013, 85, 3730–3738. DOI: 10.1021/ac3037365.
  • Citti, C.; Pacchetti, B.; Vandelli, M. A.; Forni, F.; Cannazza, G. Analysis of Cannabinoids in Commercial Hemp Seed Oil and Decarboxylation Kinetics Studies of Cannabidiolic Acid (CBDA). J. Pharm. Biomed. Anal. 2018, 149, 532–540. DOI: 10.1016/j.jpba.2017.11.044.
  • Shevyrin, V.; Melkozerov, V.; Nevero, A.; Eltsov, O. S.; Shafran, Y. Analytical Characterization of Some Synthetic Cannabinoids, Derivatives of Indole-3-Carboxylic Acid. Forensic Sci. Int. 2013, 232, 1–10. DOI: 10.1016/j.forsciint.2013.06.011.
  • Kneisel, S.; Speck, M.; Moosmann, B.; Corneillie, T. M.; Butlin, N. G.; Auwarter, V. LC/ESI-MS/MS Method for Quantification of 28 Synthetic Cannabinoids in Neat Oral Fluid and Its Application to Preliminary Studies on Their Detection Windows. Anal. Bioanal. Chem. 2013, 405, 4691–4706. DOI: 10.1007/s00216-013-6887-0.
  • Leghissa, A.; Smuts, J.; Qiu, C.; Hildenbrand, Z. L.; Schug, K. A. Detection of Cannabinoids and Cannabinoid Metabolites Using Gas Chromatography with Vacuum Ultraviolet Spectroscopy. Sep. Sci. Plus. 2018, 1, 37–42. DOI: 10.1002/sscp.201700005.
  • Kieliba, T.; Lerch, O.; Andresen-Streichert, H.; Rothschild, M. A.; Beike, J. Simultaneous Quantification of THC-COOH, OH-THC, and Further Cannabinoids in Human Hair by Gas Chromatography-Tandem Mass Spectrometry with Electron Ionization Applying Automated Sample Preparation. Drug Test Anal. 2019, 11, 267–278. DOI: 10.1002/dta.2490.
  • Sundstrom, M.; Pelander, A.; Angerer, V.; Hutter, M.; Kneisel, S.; Ojanpera, I. A High-Sensitivity Ultra-High Performance Liquid Chromatography/High-Resolution Time-of-Flight Mass Spectrometry (UHPLC-HR-TOFMS) Method for Screening Synthetic Cannabinoids and Other Drugs of Abuse in Urine. Anal. Bioanal. Chem. 2013, 405, 8463–8474. DOI: 10.1007/s00216-013-7272-8.
  • Wei, B.; McGuffey, J. E.; Blount, B. C.; Wang, L. Sensitive Quantification of Cannabinoids in Milk by Alkaline Saponification-Solid Phase Extraction Combined with Isotope Dilution UPLC-MS/MS. ACS Omega 2016, 1, 1307–1313. DOI: 10.1021/acsomega.6b00253.
  • Simões, S. S.; Silva, I.; Ajenjo, A. C.; Dias, M. J. Validation and Application of an UPLC–MS/MS Method for the Quantification of Synthetic Cannabinoids in Urine Samples and Analysis of Seized Materials from the Portuguese Market. Forensic Sci. Int. 2014, 243, 117–125. DOI: 10.1016/j.forsciint.2014.07.022.
  • Pisciottano, I. D. M.; Guadagnuolo, G.; Soprano, V.; De Crescenzo, M.; Gallo, P. A Rapid Method to Determine Nine Natural Cannabinoids in Beverages and Food Derived from Cannabis sativa by Liquid Chromatography Coupled to Tandem Mass Spectrometry on a QTRAP 4000. Rapid Commun. Mass. Spectrom. 2018, 32, 1728–1736. DOI: 10.1002/rcm.8242.
  • Aizpurua-Olaizola, O.; Zarandona, I.; Ortiz, L.; Navarro, P.; Etxebarria, N.; Usobiaga, A. Simultaneous Quantification of Major Cannabinoids and Metabolites in Human Urine and Plasma by HPLC-MS/MS and Enzyme-Alkaline Hydrolysis. Drug Test Anal. 2017, 9, 626–633. DOI: 10.1002/dta.1998.
  • Wei, B.; Wang, L.; Blount, B. C. Analysis of Cannabinoids and Their Metabolites in Human Urine. Anal. Chem. 2015, 87, 10183–10187. DOI: 10.1021/acs.analchem.5b02603.
  • Gasse, A.; Pfeiffer, H.; Kohler, H.; Schurenkamp, J. Development and Validation of a Solid-Phase Extraction Method Using Anion Exchange Sorbent for the Analysis of Cannabinoids in Plasma and Serum by Gas Chromatography-Mass Spectrometry. Int. J. Legal Med. 2016, 130, 967–974. DOI: 10.1007/s00414-016-1368-6.
  • Schwope, D. M.; Scheidweiler, K. B.; Huestis, M. A.; Direct Quantification of Cannabinoids and Cannabinoid Glucuronides in Whole Blood by Liquid Chromatography-Tandem Mass Spectrometry. Anal. Bioanal. Chem. 2011, 401, 1273–1283. DOI: 10.1007/s00216-011-5197-7.
  • Langer, N.; Lindigkeit, R.; Schiebel, H.-M.; Papke, U.; Ernst, L.; Beuerle, T. Identification and Quantification of Synthetic Cannabinoids in "Spice-Like" Herbal Mixtures: Update of the German Situation for the Spring of 2016. Forensic Sci. Int. 2016, 269, 31–41. DOI: 10.1016/j.forsciint.2016.10.023.
  • Langer, N.; Lindigkeit, R.; Schiebel, H.; Ernst, L.; Beuerle, T. Identification and Quantification of Synthetic Cannabinoids in ‘Spice-Like' Herbal Mixtures: A Snapshot of the German Situation in the Autumn of 2012. Drug Test Anal. 2014, 6, 59–71. DOI: 10.1002/dta.1499.
  • Dresen, S.; Kneisel, S.; Weinmann, W.; Zimmermann, R.; Auwärter, V. Development and Validation of a Liquid chromatography-tandem mass spectrometry method for the quantitation of synthetic cannabinoids of the aminoalkylindole type and methanandamide in serum and its application to forensic samples. J. Mass Spectrom. 2011, 46, 163–171. DOI: 10.1002/jms.1877.
  • Oiestad, E. L.; Johansen, U.; Christophersen, A. S.; Karinen, R. J. B. Screening of Synthetic Cannabinoids in Preserved Oral Fluid by UPLC-MS/MS. Bioanalysis 2013, 5, 2257–2268. DOI: 10.4155/bio.13.182.
  • Behonick, G. S.; Shanks, K. G.; Firchau, D. J.; Mathur, G.; Lynch, C. F.; Nashelsky, M.; Jaskierny, D. J.; Meroueh, C. Four Postmortem Case Reports with Quantitative Detection of the Synthetic Cannabinoid, 5F-PB-22. J. Anal. Toxicol. 2014, 38, 559–562. DOI: 10.1093/jat/bku048.
  • Dziadosz, M.; Weller, J.; Klintschar, M.; Teske, J. Scheduled Multiple Reaction Monitoring Algorithm as a Way to Analyse New Designer Drugs Combined with Synthetic Cannabinoids in Human Serum with Liquid Chromatography-Tandem Mass Spectrometry. J. Chromatogr. B. Analyt. Technol. Biomed. Life. Sci. 2013, 929, 84–89. DOI: 10.1016/j.jchromb.2013.04.017.
  • Dong, X.; Li, L.; Ye, Y.; Zheng, L.; Jiang, Y. Simultaneous Determination of Major Phytocannabinoids, Their Main Metabolites, and Common Synthetic Cannabinoids in Urine Samples by LCMS/MS. J. Chromatogr. B. 2016, 1033-1034, 55–64. DOI: 10.1016/j.jchromb.2016.08.002.
  • Borg, D.; Tverdovsky, A.; Stripp, R. A Fast and Comprehensive Analysis of 32 Synthetic Cannabinoids Using Agilent Triple Quadrupole LC-MS-MS. J. Anal. Toxicol. 2017, 41, 6–16. DOI: 10.1093/jat/bkw104.
  • Freijo, T. D.; Harris, S. E.; Kala, S. V. A Rapid Quantitative Method for the Analysis of Synthetic Cannabinoids by Liquid Chromatography-Tandem Mass Spectrometry. J. Anal. Toxicol. 2014, 38, 466–478. DOI: 10.1093/jat/bku092.
  • Berg, T.; Kaur, L.; Risnes, A.; Havig, S. M.; Karinen, R. Determination of a Selection of Synthetic Cannabinoids and Metabolites in Urine by UHPSFC-MS/MS and by UHPLC-MS/MS. Drug Test Anal. 2016, 8, 708–722. DOI: 10.1002/dta.1844.
  • Ravula, A.; Chandasana, H.; Setlow, B.; Febo, M.; Bruijnzeel, A. W.; Derendorf, H. Simultaneous Quantification of Cannabinoids Tetrahydrocannabinol, Cannabidiol and CB1 Receptor Antagonist in Rat Plasma: An Application to Characterize Pharmacokinetics after Passive Cannabis Smoke Inhalation and co-Administration of Rimonabant. J. Pharm. Biomed. Anal. 2018, 160, 119–125. DOI: 10.1016/j.jpba.2018.07.004.
  • Ammann, J.; McLaren, J. M.; Gerostamoulos, D.; Beyer, J. Detection and Quantification of New Designer Drugs in Human Blood: Part 1 - Synthetic Cannabinoids. J. Anal. Toxicol. 2012, 36, 372–380. DOI: 10.1093/jat/bks048.
  • Fort, C.; Jourdan, T. H.; Kemp, J.; Curtis, B. J. J. o A. T. Stability of Synthetic Cannabinoids in Biological Specimens: Analysis through Liquid Chromatography Tandem Mass Spectrometry. J. Anal. Toxicol. 2017, 41, 360. DOI: 10.1093/jat/bkx015.
  • Han, E.; Park, Y.; Kim, E.; In, S.; Yang, W.; Lee, S.; Choi, H.; Lee, S.; Chung, H.; Song, J. M. Simultaneous Analysis of Δ(9)-Tetrahydrocannabinol and 11-nor-9-Carboxy-Tetrahydrocannabinol in Hair Without Different Sample Preparation and Derivatization by Gas Chromatography-Tandem Mass Spectrometry. J. Pharm. Biomed. Anal. 2011, 55, 1096–1103. DOI: 10.1016/j.jpba.2011.03.020.
  • Agarwal, C.; Mathe, K.; Hofmann, T.; Csoka, L. Ultrasound-Assisted Extraction of Cannabinoids from Cannabis sativa L. Optimized by Response Surface Methodology. J. Food Sci. 2018, 83, 700–710. DOI: 10.1111/1750-3841.14075.
  • Shanks, K. G.; Tim, D.; George, B.; Andrea, T. Analysis of First and Second Generation Legal Highs for Synthetic Cannabinoids and Synthetic Stimulants by Ultra-Performance Liquid Chromatography and Time of Flight Mass Spectrometry. J. Anal. Toxicol. 2012, 36, 360–371.
  • Pellati, F.; Brighenti, V.; Sperlea, J.; Marchetti, L.; Bertelli, D.; Benvenuti, S. J. M. New Methods for the Comprehensive Analysis of Bioactive Compounds in Cannabis sativa L. (hemp). Molecules 2018, 23, 2639. DOI: 10.3390/molecules23102639.
  • Berman, P.; Futoran, K.; Lewitus, G. M.; Mukha, D.; Benami, M.; Shlomi, T.; Meiri, D. A New ESI-LC/MS Approach for Comprehensive Metabolic Profiling of Phytocannabinoids in Cannabis. Sci. Rep. 2018, 8, 14280. DOI: 10.1038/s41598-018-32651-4.
  • Ciolino, L. A.; Ranieri, T. L.; Taylor, A. M. Commercial Cannabis Consumer Products Part 2: HPLC-DAD Quantitative Analysis of Cannabis cannabinoids. Forensic Sci. Int. 2018, 289, 438–447. DOI: 10.1016/j.forsciint.2018.05.033.
  • Chang, C.; Tung, C.; Tsai, C.; Wu, Y.; Hsu, M. Determination of Cannabinoids in Hemp Nut Products in Taiwan by HPLC-MS/MS Coupled With Chemometric Analysis: Quality Evaluation and a Pilot Human Study. Drug Test Anal. 2017, 9, 888–897. DOI: 10.1002/dta.2062.
  • Happyana, N.; Agnolet, S.; Muntendam, R.; Van Dam, A.; Schneider, B.; Kayser, O. Analysis of Cannabinoids in Laser-Microdissected Trichomes of Medicinal Cannabis sativa Using LCMS and Cryogenic NMR. Phytochemistry 2013, 87, 51–59. DOI: 10.1016/j.phytochem.2012.11.001.
  • Meng, Q.; Buchanan, B.; Zuccolo, J.; Poulin, M.; Gabriele, J.; Baranowski, D. C. A Reliable and Validated LC-MS/MS Method for the Simultaneous Quantification of 4 Cannabinoids in 40 Consumer Products. PLoS One 2018, 13, e0196396. DOI: 10.1371/journal.pone.0196396.
  • Ciolino, L. A. J. J. o F. S. Quantitation of Synthetic Cannabinoids in Plant Materials Using High Performance Liquid Chromatography with UV Detection (Validated Method). J. Forensic. Sci. 2015, 60, 1171–1181. DOI: 10.1111/1556-4029.12795.
  • Cheng, H.-L.; Tsai, Y.-H.; Hsu, W.-L.; Lin, Y.-H. An On-line Stacking Capillary Electrophoresis Method for the Analysis of Δ(9)-Tetrahydrocannabinol and Its Metabolites. J. Chromatogr. A. 2015, 1426, 226–232. DOI: 10.1016/j.chroma.2015.11.032.
  • Ibanez, M.; Bijlsma, L.; Van Nuijs, A. L. N.; Sancho, J. V.; Haro, G.; Covaci, A.; Hernandez, F. Quadrupole-time-of-flight mass spectrometry screening for synthetic cannabinoids in herbal blends. J. Mass Spectrom. 2013, 48, 685–694. DOI: 10.1002/jms.3217.
  • Zivovinovic, S.; Alder, R.; Allenspach, M. D. Determination of Cannabinoids in Cannabis sativa L. samples for Recreational, Medical, and Forensic Purposes by Reversed-Phase Liquid Chromatography-Ultraviolet Detection. J. Anal. Sci. Technol. 2018, 9, 1.
  • Pacifici, R.; Marchei, E.; Salvatore, F.; Guandalini, L.; Busardo, F. P.; Pichini, S. Evaluation of Cannabinoids Concentration and Stability in Standardized Preparations of Cannabis Tea and Cannabis Oil by Ultra-High Performance Liquid Chromatography Tandem Mass Spectrometry. Clin. Chem. Lab. Med. 2017, 55, 1555–1563. DOI: 10.1515/cclm-2016-1060.
  • Tose, L. V.; Santos, N. A. D.; Rodrigues, R. R. T.; Murgu, M.; Gomes, A.; Vasconcelos, G. A.; Souza, P. C. T.; Vaz, B. G.; Romao, W. Isomeric Separation of Cannabinoids by UPLC Combined with Ionic Mobility Mass Spectrometry (TWIM-MS)-Part I. Int. J. Mass Spectrom. 2017, 418, 112–121. DOI: 10.1016/j.ijms.2016.10.018.
  • Pandohee, J.; Holland, B. J.; Li, B.; Tsuzuki, T.; Stevenson, P. G.; Barnett, N. W.; Pearson, J. R.; Jones, O. A. H.; Conlan, X. A. Screening of Cannabinoids in Industrial-Grade Hemp Using Two-Dimensional Liquid Chromatography Coupled with Acidic Potassium Permanganate Chemiluminescence Detection. J. Sep. Sci. 2015, 38, 2024–2032. DOI: 10.1002/jssc.201500088.
  • Patel, B.; Wene, D.; Fan, Z. Qualitative and Quantitative Measurement of Cannabinoids in Cannabis Using Modified HPLC/DAD Method. J. Pharm. Biomed. Anal. 2017, 146, 15–23. DOI: 10.1016/j.jpba.2017.07.021.
  • Rovetto, L. J.; Aieta, N. V. Supercritical Carbon Dioxide Extraction of Cannabinoids from Cannabis sativa L. J. Supercrit. Fluids 2017, 129, 16–27. DOI: 10.1016/j.supflu.2017.03.014.
  • Aizpuruaolaizola, O.; Omar, J.; Navarro, P.; Olivares, M.; Etxebarria, N.; Usobiaga, A. Identification and Quantification of Cannabinoids in Cannabis sativa L. plants by High Performance Liquid Chromatography-Mass Spectrometry. Anal. Bioanal. Chem. 2014, 406, 7549–7560. DOI: 10.1007/s00216-014-8177-x.
  • Lewis, M. M.; Yang, Y.; Wasilewski, E.; Clarke, H. A.; Kotra, L. P. Chemical Profiling of Medical Cannabis Extracts. ACS Omega. 2017, 2, 6091–6103. DOI: 10.1021/acsomega.7b00996.
  • Brighenti, V.; Pellati, F.; Steinbach, M.; Maran, D.; Benvenuti, S. Development of a New Extraction Technique and HPLC Method for the Analysis of Non-Psychoactive Cannabinoids in Fibre-Type Cannabis sativa L. (hemp). J. Pharm. Biomed. Anal. 2017, 143, 228–236. DOI: 10.1016/j.jpba.2017.05.049.
  • Sergi, M.; Montesano, C.; Odoardi, S.; Rocca, L. M.; Fabrizi, G.; Compagnone, D.; Curini, R. J. Micro Extraction by Packed Sorbent Coupled to Liquid Chromatography Tandem Mass Spectrometry for the Rapid and Sensitive Determination of Cannabinoids in Oral Fluids. J. Chromatogr. A. 2013, 1301, 139–146. DOI: 10.1016/j.chroma.2013.05.072.
  • Cox, A. O.; Daw, R. C.; Mason, M. D.; Grabenauer, M.; Pande, P. G.; Davis, K. H.; Wiley, J. L.; Stout, P. R.; Thomas, B. F.; Huffman, J. W. Use of SPME-HS-GC-MS for the Analysis of Herbal Products Containing Synthetic Cannabinoids. J. Anal. Toxicol. 2012, 36, 293–302. DOI: 10.1093/jat/bks025.
  • Sartore, D. M.; Vargas Medina, D. A.; Costa, J. L.; Lanças, F. M.; Santos-Neto, Á. J. Automated Microextraction by Packed Sorbent of Cannabinoids from Human Urine Using a Lab-Made Device Packed with Molecularly Imprinted Polymer. Talanta 2020, 219, 121185. DOI: 10.1016/j.talanta.2020.121185.
  • Silveira, G. d O.; Loddi, S.; de Oliveira, C. D. R.; Zucoloto, A. D.; Fruchtengarten, L. V. G.; Yonamine, M. Headspace Solid-Phase Microextraction and Gas Chromatography − Mass Spectrometry for Determination of Cannabinoids in Human Breast Milk. Forensic Toxicol. 2017, 35, 125–132. DOI: 10.1007/s11419-016-0346-5.
  • Jornet-Martínez, N.; Ortega-Sierra, A.; Verdú-Andrés, J.; Herráez-Hernández, R.; Campíns-Falcó, P. Analysis of Contact Traces of Cannabis by in-Tube Solid-Phase Microextraction Coupled to Nanoliquid Chromatography. Molecules 2018, 23, 2359. DOI: 10.3390/molecules23092359.
  • Moradi, M.; Yamini, Y.; Baheri, T. Analysis of Abuse Drugs in Urine Using Surfactant-Assisted Dispersive Liquid-Liquid Microextraction. J. Sep. Sci. 2011, 34, 1722–1729. DOI: 10.1002/jssc.201100132.
  • Yanes, E. G.; Lovett, D. P. High-Throughput Bioanalytical Method for Analysis of Synthetic Cannabinoid Metabolites in Urine Using Salting-out Sample Preparation and LC-MS/MS. J. Chromatogr. B. Analyt. Technol. Biomed. Life. Sci. 2012, 909, 42–50. DOI: 10.1016/j.jchromb.2012.10.013.
  • Scheidweiler, K. B.; Newmeyer, M. N.; Barnes, A. J.; Huestis, M. A. Quantification of Cannabinoids and Their Free and Glucuronide Metabolites in Whole Blood by Disposable Pipette Extraction and Liquid Chromatography-Tandem Mass Spectrometry. J. Chromatogr. A. 2016, 1453, 34–42. DOI: 10.1016/j.chroma.2016.05.024.
  • Serna-Loaiza, S.; Adamcyk, J.; Beisl, S.; Kornpointner, C.; Halbwirth, H.; Friedl, A. Pressurized Liquid Extraction of Cannabinoids from Hemp Processing Residues: Evaluation of the Influencing Variables. Processes 2020, 8, 1334. DOI: 10.3390/pr8111334.
  • Montesano, C.; Simeoni, M. C.; Vannutelli, G.; Gregori, A.; Ripani, L.; Sergi, M.; Compagnone, D.; Curini, R. Pressurized Liquid Extraction for the Determination of Cannabinoids and Metabolites in Hair: Detection of Cut-off Values by High Performance Liquid chromatography-high resolution tandem mass spectrometry. J. Chromatogr. A. 2015, 1406, 192–200. DOI: 10.1016/j.chroma.2015.06.021.
  • Ribeiro Grijó, D.; Vieitez Osorio, I. A.; Cardozo-Filho, L. Supercritical Extraction Strategies Using CO2 and Ethanol to Obtain Cannabinoid Compounds from Cannabis Hybrid Flowers. J. CO2 Util. 2019, 30, 241–248. DOI: 10.1016/j.jcou.2018.12.014.
  • Kneisel, S.; Auwarter, V. Analysis of 30 Synthetic Cannabinoids in Serum by Liquid Chromatography-Electrospray Ionization Tandem Mass Spectrometry After Liquid-Liquid Extraction. J. Mass Spectrom. 2012, 47, 825–835. DOI: 10.1002/jms.3020.
  • Franz, F.; Jechle, H.; Angerer, V.; Pegoro, M.; Auwärter, V.; Neukamm, M. A. Synthetic Cannabinoids in Hair – Pragmatic Approach for Method Updates, Compound Prevalences and Concentration Ranges in Authentic Hair Samples. Anal. Chim. Acta 2018, 1006, 61–73. DOI: 10.1016/j.aca.2017.12.029.
  • Kim, J.; In, S.; Park, Y.; Park, M.; Kim, E.; Lee, S. Deposition of JWH-018, JWH-073 and Their Metabolites in Hair and Effect of Hair Pigmentation. Anal. Bioanal. Chem. 2013, 405, 9769–9778. DOI: 10.1007/s00216-013-7423-y.
  • Gottardo, R.; Sorio, D.; Musile, G.; Trapani, E.; Seri, C.; Serpelloni, G.; Tagliaro, F. J. M. S.; Law, T. Screening for Synthetic Cannabinoids in Hair by Using LC-QTOF MS: A New and Powerful Approach to Study the Penetration of These New Psychoactive Substances in the Population. Med. Sci. Law. 2014, 54, 22–27. DOI: 10.1177/0025802413477396.
  • Emídio, E. S.; de Menezes Prata, V.; de Santana, F. J. M.; Dórea, H. S. Hollow Fiber-Based Liquid Phase Microextraction With Factorial Design Optimization and Gas Chromatography-Tandem Mass Spectrometry for Determination of Cannabinoids in Human Hair. J. Chromatogr. B. Analyt. Technol. Biomed. Life. Sci. 2010, 878, 2175–2183. DOI: 10.1016/j.jchromb.2010.06.005.
  • Desrosiers, N. A.; Scheidweiler, K. B.; Huestis, M. A. J. D. T. Quantification of Six Cannabinoids and Metabolites in Oral Fluid by Liquid Chromatography-Tandem Mass Spectrometry. Drug Test Anal. 2015, 7, 684–694. DOI: 10.1002/dta.1753.
  • Marchei, E.; Escuder, D.; Pallas, C. R.; Garcia-Algar, O.; Gómez, A.; Friguls, B.; Pellegrini, M.; Pichini, S. Simultaneous Analysis of Frequently Used Licit and Illicit Psychoactive Drugs in Breast Milk by Liquid Chromatography Tandem Mass Spectrometry. J. Pharm. Biomed. Anal. 2011, 55, 309–316. DOI: 10.1016/j.jpba.2011.01.028.
  • Sergi, M.; Battista, N.; Montesano, C.; Curini, R.; Maccarrone, M.; Compagnone, D. Determination of the Two Major Endocannabinoids in Human Plasma by μ-SPE Followed by HPLC-MS/MS. Anal. Bioanal. Chem. 2013, 405, 785–793. DOI: 10.1007/s00216-012-6273-3.
  • Anzillotti, L.; Castrignanò, E.; Strano Rossi, S.; Chiarotti, M. Cannabinoids Determination in Oral Fluid by SPME-GC/MS and UHPLC-MS/MS and Its Application on Suspected Drivers. Sci. Justice 2014, 54, 421–426. DOI: 10.1016/j.scijus.2014.08.004.
  • Hasegawa, K.; Minakata, K.; Gonmori, K.; Nozawa, H.; Yamagishi, I.; Watanabe, K.; Suzuki, O. Identification and Quantification of Predominant Metabolites of Synthetic Cannabinoid MAB-CHMINACA in an Authentic Human Urine Specimen. Drug Test Anal. 2018, 10, 365–371. DOI: 10.1002/dta.2220.
  • Brighenti, V.; Licata, M.; Pedrazzi, T.; Maran, D.; Bertelli, D.; Pellati, F.; Benvenuti, S. Development of a New method for the Analysis of Cannabinoids in Honey by Means of High-Performance Liquid Chromatography Coupled With Electrospray Ionisation-Tandem Mass Spectrometry Detection. J. Chromatogr. A. 2019, 1597, 179–186. DOI: 10.1016/j.chroma.2019.03.034.
  • Heo, S.; Yoo, G. J.; Choi, J. Y.; Park, H. J.; Do, J.-A.; Cho, S.; Baek, S. Y.; Park, S.-K. Simultaneous Analysis of Cannabinoid and Synthetic Cannabinoids in Dietary Supplements Using UPLC with UV and UPLC–MS-MS. J. Anal. Toxicol. 2016, 40, 350–359. DOI: 10.1093/jat/bkw027.
  • Lossing, F. P.; Tanaka, I. J. Photoionization as a Source of Ions for Mass Spectrometry. J. Chem. Phys. 1956, 25, 1031–1034. DOI: 10.1063/1.1743092.
  • Kim, J. H.; Park, Y.; Park, M.; Kim, E.; Yang, W.; Baeck, S.; Lee, S.; Han, S. Simultaneous Determination of Five Naphthoylindole-Based Synthetic Cannabinoids and Metabolites and Their Deposition in Human and Rat Hair. J. Pharm. Biomed. Anal. 2015, 102, 162–175. DOI: 10.1016/j.jpba.2014.09.013.
  • Sekuła, K.; Zuba, D.; Lorek, K. Analysis of Fragmentation Pathways of New-Type Synthetic Cannabinoids Using Electrospray Ionization. J. Am. Soc. Mass Spectrom. 2018, 29, 1941–1950. DOI: 10.1007/s13361-018-2008-9.
  • Holm, N. B.; Pineda, R. S.; Andersen, D. W.; Rasmussen, B. S.; Dalsgaard, P. W.; Hoegberg, L. C. G.; Johansen, S. S.; Linnet, K. Screening of Danish Traffic Cases for Synthetic Cannabinoids in Whole Blood by LC-MS/MS. Scand. J. Forensic Sci. 2013, 19, 45–51. DOI: 10.2478/sjfs-2013-0008.
  • Destefano, J.; Schuster, S.; Lawhorn, J.; Kirkland, J. Performance Characteristics of New Superficially Porous Particles. J. Chromatogr. A. 2012, 1258, 76–83. DOI: 10.1016/j.chroma.2012.08.036.
  • Zaitsu, K.; Nakayama, H.; Yamanaka, M.; Hisatsune, K.; Taki, K.; Asano, T.; Kamata, T.; Katagai, M.; Hayashi, Y.; Kusano, M.; et al. High-Resolution Mass Spectrometric Determination of the Synthetic Cannabinoids MAM-2201, AM-2201, AM-2232, and Their Metabolites in Postmortem Plasma and Urine by LC/Q-TOFMS. Int. J. Legal Med. 2015, 129, 1233–1245., DOI: 10.1007/s00414-015-1257-4.
  • Hutter, M.; Broecker, S.; Kneisel, S.; Auwärter, V. Identification of the Major Urinary Metabolites in Man of Seven Synthetic Cannabinoids of the Aminoalkylindole Type Present as Adulterants in ‘Herbal Mixtures’ Using LC-MS/MS Techniques. J. Mass Spectrom. 2012, 47, 54–65. DOI: 10.1002/jms.2026.
  • Poklis, J. L.; Wolf, C. E.; Eljordi, O. I.; Liu, K.; Zhang, S.; Poklis, A. Analysis of the First‐ and Second‐Generation Raving Dragon Novelty Bath Salts Containing Methylone and Pentedrone. J. Forensic Sci. 2015, 60, S234–S240. DOI: 10.1111/1556-4029.12629.
  • Beasley, E.; Francese, S.; Bassindale, T. Detection and Mapping of Cannabinoids in Single Hair Samples through Rapid Derivatization and Matrix-Assisted Laser Desorption Ionization Mass Spectrometry. Anal. Chem. 2016, 88, 10328–10334. DOI: 10.1021/acs.analchem.6b03551.
  • Kernalléguen, A.; Enjalbal, C.; Alvarez, J. C.; Belgacem, O.; Léonetti, G.; Lafitte, D.; Pélissier-Alicot, A. L. Synthetic Cannabinoid Isomers Characterization by MALDI-MS3 Imaging: Application to Single Scalp Hair. Anal. Chim. Acta. 2018, 1041, 87–93. DOI: 10.1016/j.aca.2018.09.036.
  • Conti, M.; Tazzari, V.; Bertona, M.; Brambilla, M.; Brambilla, P. Surface-Activated Chemical Ionization Combined with Electrospray Ionization and Mass Spectrometry for the Analysis of Cannabinoids in Biological Samples. Part I: Analysis of 11-nor-9-Carboxytetrahydro-Cannabinol. Rapid Commun. Mass. Spectrom. 2011, 25, 1552–1558. DOI: 10.1002/rcm.5029.
  • Strano-Rossi, S.; Anzillotti, L.; Castrignanò, E.; Romolo, F. S.; Chiarotti, M. Ultra High Performance Liquid Chromatography-Electrospray Ionization-Tandem Mass Spectrometry Screening Method for Direct Analysis of Designer Drugs, "Spice" and Stimulants in Oral Fluid. J. Chromatogr. A. 2012, 1258, 37–42. DOI: 10.1016/j.chroma.2012.07.098.
  • Ambroziak, K.; Adamowicz, P. Simple Screening Procedure for 72 Synthetic Cannabinoids in Whole Blood by Liquid Chromatography-Tandem Mass Spectrometry. Forensic Toxicol. 2018, 36, 280–290. DOI: 10.1007/s11419-017-0401-x.
  • Stolker, A. A. M.; Schoonhoven, J.; de Vries, A.; Bobeldijk Pastorova, I.; Vaes, W.; Berg, R. Determination of Cannabinoids in Cannabis Products Using Liquid Chromatography-Ion Trap Mass Spectrometry. J Chromatogr. A. 2004, 1058, 143–151. DOI: 10.1016/S0021-9673(04)01447-5.
  • Calvi, L.; Pentimalli, D.; Panseri, S.; Giupponi, L.; Gelmini, F.; Beretta, G.; Vitali, D.; Bruno, M.; Zilio, E.; Pavlovic, R.; Giorgi, A. Comprehensive Quality Evaluation of Medical Cannabis sativa L. inflorescence and Macerated Oils Based on HS-SPME Coupled to GC-MS and LC-HRMS (q-exactive orbitrap®) Approach. J. Pharm. Biomed. Anal. 2018, 150, 208–219. DOI: 10.1016/j.jpba.2017.11.073.
  • Habala, L.; Valentova, J.; Pechova, I.; Fuknova, M.; Devinsky, F. DART - LTQ ORBITRAP as an Expedient Tool for the Identification Of Synthetic Cannabinoids. Leg. Med. (Tokyo) 2016, 20, 27–31. DOI: 10.1016/j.legalmed.2016.03.006.
  • Gwak, S.; Almirall, J. R. Rapid Screening of 35 New Psychoactive Substances by Ion Mobility Spectrometry (IMS) and Direct Analysis in Real Time (DART) Coupled to Quadrupole Time-of-Flight Mass Spectrometry (QTOF-MS). Drug Test Anal. 2015, 7, 884–893. DOI: 10.1002/dta.1783.
  • Scheidweiler, K. B.; Jarvis, M.; Huestis, M. A. Nontargeted SWATH Acquisition for Identifying 47 Synthetic Cannabinoid Metabolites in Human Urine by Liquid Chromatography-High-Resolution Tandem Mass Spectrometry. Anal. Bioanal. Chem. 2015, 407, 883–897. DOI: 10.1007/s00216-014-8118-8.
  • Grabenauer, M.; Krol, W. L.; Wiley, J. L.; Thomas, B. F. Analysis of Synthetic Cannabinoids Using High-Resolution Mass Spectrometry and Mass Defect Filtering: Implications for Nontargeted Screening of Designer Drugs. Anal. Chem. 2012, 84, 5574–5581. DOI: 10.1021/ac300509h.
  • Tassoni, G.; Cippitelli, M.; Ottaviani, G.; Froldi, R.; Cingolani, M. Detection of Cannabinoids by ELISA and GC-MS Methods in a Hair Sample Previously Used to Detect Other Drugs of Abuse. J. Anal. Toxicol. 2016, 40, 408–413. DOI: 10.1093/jat/bkv120.
  • Omar, J.; Olivares, M.; Amigo, J. M.; Etxebarria, N. Resolution of co-Eluting Compounds of Cannabis sativa in Comprehensive Two-Dimensional Gas Chromatography/Mass Spectrometry Detection with Multivariate Curve Resolution-Alternating Least Squares. Talanta 2014, 121, 273–280. DOI: 10.1016/j.talanta.2013.12.044.
  • Akutsu, M.; Sugie, K.; Saito, K. Analysis of 62 Synthetic Cannabinoids by Gas Chromatography-Mass Spectrometry With Photoionization. Forensic Toxicol. 2017, 35, 94–103. DOI: 10.1007/s11419-016-0342-9.
  • Cardenia, V.; Toschi, T. G.; Scappini, S.; Rubino, R. C.; Rodriguezestrada, M. T. Development and Validation of a Fast Gas Chromatography/Mass Spectrometry Method for the Determination of Cannabinoids in Cannabis sativa L. J. Food Drug Anal. 2018, 26, 1283–1292. DOI: 10.1016/j.jfda.2018.06.001.
  • Toyo'oka, T.; Kikura-Hanajiri, R. A Reliable Method for the Separation and Detection of Synthetic Cannabinoids by Supercritical Fluid Chromatography with Mass Spectrometry, and Its Application to Plant Products. Chem. Pharm. Bull. (Tokyo) 2015, 63, 762–769. DOI: 10.1248/cpb.c15-00170.
  • Breitenbach, S.; Rowe, W. F.; McCord, B.; Lurie, I. S. Assessment of Ultra High Performance Supercritical Fluid Chromatography as a Separation Technique for the Analysis of Seized Drugs: Applicability to Synthetic Cannabinoids. J. Chromatogr. A. 2016, 1440, 201–211. DOI: 10.1016/j.chroma.2016.02.047.
  • Iwamuro, Y.; Iio-Ishimaru, R.; Chinaka, S.; Takayama, N.; Hayakawa, K. Analysis of 11-nor-Δ9 -Tetrahydrocannabinol-9-Carboxylic Acid and Its Glucuronide in Urine by Capillary Electrophoresis/Mass Spectrometry. Biomed. Chromatogr. 2012, 26, 1452–1456. DOI: 10.1002/bmc.2719.
  • Akamatsu, S.; Mitsuhashi, T. J. MEKC-MS/MS Method Using a Volatile Surfactant for the Simultaneous Determination of 12 Synthetic Cannabinoids. J. Sep. Sci. 2014, 37, 304–307. DOI: 10.1002/jssc.201301132.
  • Barnes, A. J.; Young, S.; Spinelli, E.; Martin, T. M.; Klette, K. L.; Huestis, M. A. Evaluation of a homogenous enzyme immunoassay for the detection of synthetic cannabinoids in urine. Forensic Sci. Int. 2014, 241, 27–34. DOI: 10.1016/j.forsciint.2014.04.020.
  • Arntson, A.; Ofsa, B.; Lancaster, D.; Simon, J. R.; Mcmullin, M.; Logan, B. K. Validation of a Novel Immunoassay for the Detection of Synthetic Cannabinoids and Metabolites in Urine Specimens. J. Anal. Toxicol. 2013, 37, 284–290. DOI: 10.1093/jat/bkt024.
  • Nissim, R.; Compton, R. G. Absorptive stripping voltammetry for cannabis detection. Chem. Cent. J. 2015, 9, 41. DOI: 10.1186/s13065-015-0117-0.
  • Deriu, C.; Conticello, I.; Mebel, A. M.; McCord B. Micro Solid Phase Extraction Surface-Enhanced Raman Spectroscopy (μ-SPE/SERS) Screening Test for the Detection of the Synthetic Cannabinoid JWH-018 in Oral Fluid. Anal. Chem. 2019, 91, 4780–4789. DOI: 10.1021/acs.analchem.9b00335.
  • Gandhi, A. S.; Zhu, M.; Pang, S.; Wohlfarth, A.; Scheidweiler, K. B.; Huestis M. A. Metabolite profiling of RCS-4, a novel synthetic cannabinoid designer drug, using human hepatocyte metabolism and TOF-MS. Bioanalysis. 2014, 6, 1471–1485. DOI: 10.4155/bio.14.13.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.